Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (10443)
All Articles published online
|
Publishing Process of This Article
|
Aug 10, 2014 (publication date) through Nov 26, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Clinical Oncology
ISSN
2218-4333
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Moyret-Lalle C, Ruiz E, Puisieux A. Epithelial-mesenchymal transition transcription factors and miRNAs: “Plastic surgeons” of breast cancer. World J Clin Oncol 2014; 5(3): 311-322 [PMID: 25114847 DOI: 10.5306/wjco.v5.i3.311] |
|---|---|
| URL: | https://www.wjgnet.com/2218-4333/full/v5/i3/311.htm |
| Number | Citing Articles |
| 1 |
Maitham A. Khajah, Alyaa Al-Ateyah, Yunus A. Luqmani. MicroRNA expression profiling of endocrine sensitive and resistant breast cancer cell lines. Biochemistry and Biophysics Reports 2022; 31: 101316 doi: 10.1016/j.bbrep.2022.101316
|
| 2 |
S Ingthorsson, K Andersen, B Hilmarsdottir, G M Maelandsmo, M K Magnusson, T Gudjonsson. HER2 induced EMT and tumorigenicity in breast epithelial progenitor cells is inhibited by coexpression of EGFR. Oncogene 2016; 35(32): 4244 doi: 10.1038/onc.2015.489
|
| 3 |
Nastaran Mohammadi Ghahhari, Sadegh Babashah. Interplay between microRNAs and WNT/β-catenin signalling pathway regulates epithelial–mesenchymal transition in cancer. European Journal of Cancer 2015; 51(12): 1638 doi: 10.1016/j.ejca.2015.04.021
|
| 4 |
Fei Liu, Li-Na Gu, Bao-En Shan, Cui-Zhi Geng, Mei-Xiang Sang. Biomarkers for EMT and MET in breast cancer: An update. Oncology Letters 2016; 12(6): 4869 doi: 10.3892/ol.2016.5369
|
| 5 |
Evgeny V. Denisov, Mohit Kumar Jolly, Vitaly P. Shubin, Alexey S. Tsukanov, Nadezhda V. Cherdyntseva. Approaching Complex Diseases. Human Perspectives in Health Sciences and Technology 2020; 2: 213 doi: 10.1007/978-3-030-32857-3_10
|
| 6 |
Megan Mladinich, Diane Ruan, Chia-Hsin Chan, Robert Gourdie. Tackling Cancer Stem Cells via Inhibition of EMT Transcription Factors. Stem Cells International 2016; 2016(1) doi: 10.1155/2016/5285892
|
| 7 |
Busra Buyuk, Sha Jin, Kaiming Ye. Epithelial-to-Mesenchymal Transition Signaling Pathways Responsible for Breast Cancer Metastasis. Cellular and Molecular Bioengineering 2022; 15(1): 1 doi: 10.1007/s12195-021-00694-9
|
| 8 |
Lenka Kalinkova, Nataliia Nikolaieva, Bozena Smolkova, Sona Ciernikova, Karol Kajo, Vladimir Bella, Viera Horvathova Kajabova, Helena Kosnacova, Gabriel Minarik, Ivana Fridrichova. miR-205-5p Downregulation and ZEB1 Upregulation Characterize the Disseminated Tumor Cells in Patients with Invasive Ductal Breast Cancer. International Journal of Molecular Sciences 2021; 23(1): 103 doi: 10.3390/ijms23010103
|
| 9 |
Shaohua Chen, Daohai Zhang. Friend or foe: Endoplasmic reticulum protein 29 (ERp29) in epithelial cancer. FEBS Open Bio 2015; 5(1): 91 doi: 10.1016/j.fob.2015.01.004
|
| 10 |
Caroline Moyret-Lalle, Roxane Pommier, Charlotte Bouard, Ebticem Nouri, Geoffrey Richard, Alain Puisieux. Plasticité des cellules cancéreuses et dissémination métastatique. médecine/sciences 2016; 32(8-9): 725 doi: 10.1051/medsci/20163208020
|
| 11 |
R. Portillo-Lara, N. Annabi. Microengineered cancer-on-a-chip platforms to study the metastatic microenvironment. Lab on a Chip 2016; 16(21): 4063 doi: 10.1039/C6LC00718J
|
| 12 |
Han-xiang Zhan, Jian-wei Xu, Dong Wu, Tai-ping Zhang, San-yuan Hu. Pancreatic cancer stem cells: New insight into a stubborn disease. Cancer Letters 2015; 357(2): 429 doi: 10.1016/j.canlet.2014.12.004
|
| 13 |
Siri Amanda Tvingsholm, Ditte Marie Brix, Tuula Kallunki. Molecular and Transcriptional Signatures for ErbB2-Induced Invasion. Current Pharmacology Reports 2019; 5(1): 43 doi: 10.1007/s40495-018-0146-1
|
| 14 |
Ivana Fridrichova, Lenka Kalinkova, Sona Ciernikova. Clinical Relevancy of Circulating Tumor Cells in Breast Cancer: Epithelial or Mesenchymal Characteristics, Single Cells or Clusters?. International Journal of Molecular Sciences 2022; 23(20): 12141 doi: 10.3390/ijms232012141
|
| 15 |
Zhengjie Lin, Guanyi Luo, Weixiang Du, Tiantian Kong, Changkun Liu, Zhou Liu. Recent Advances in Microfluidic Platforms Applied in Cancer Metastasis: Circulating Tumor Cells' (CTCs) Isolation and Tumor‐On‐A‐Chip. Small 2020; 16(9) doi: 10.1002/smll.201903899
|
| 16 |
Wenjun Guo, Wulei Hou, Qin Xiang, Cheng Chen, Heng Yang, Shuaihu Li, Linhui Ye, Tian Xiao, Lizhi Zhu, Yongdong Zou, Duo Zheng. MicroRNA-1205 promotes breast cancer cell metastasis by regulating epithelial-to-mesenchymal transition via targeting of CDK3. Cellular Signalling 2024; 121: 111264 doi: 10.1016/j.cellsig.2024.111264
|
| 17 |
Suman Kumar Ray, Sukhes Mukherjee. Epigenetic Reprogramming and Landscape of Transcriptomic
Interactions: Impending Therapeutic Interference of Triple-Negative
Breast Cancer in Molecular Medicine. Current Molecular Medicine 2022; 22(10): 835 doi: 10.2174/1566524021666211206092437
|
| 18 |
Mohammed A. Aleskandarany, Ian O. Ellis, Emad A. Rakha. Precision Molecular Pathology of Breast Cancer. Molecular Pathology Library 2015; 10: 271 doi: 10.1007/978-1-4939-2886-6_16
|
| 19 |
Mariana Segovia-Mendoza, Susana Romero-Garcia, Cristina Lemini, Heriberto Prado-Garcia, francesca bianchi. Determining Factors in the Therapeutic Success of Checkpoint Immunotherapies against PD-L1 in Breast Cancer: A Focus on Epithelial-Mesenchymal Transition Activation. Journal of Immunology Research 2021; 2021: 1 doi: 10.1155/2021/6668573
|
| 20 |
Michel-Gael F. Guefack, Debojit Talukdar, Rimi Mukherjee, Subhabrata Guha, Debarpan Mitra, Depanwita Saha, Gaurav Das, François Damen, Victor Kuete, Nabendu Murmu. Hypericum roeperianum bark extract suppresses breast cancer proliferation via induction of apoptosis, downregulation of PI3K/Akt/mTOR signaling cascade and reversal of EMT. Journal of Ethnopharmacology 2024; 319: 117093 doi: 10.1016/j.jep.2023.117093
|
| 21 |
Chloé Morin, Caroline Moyret-Lalle, Hichem C. Mertani, Jean-Jacques Diaz, Virginie Marcel. Heterogeneity and dynamic of EMT through the plasticity of ribosome and mRNA translation. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2022; 1877(3): 188718 doi: 10.1016/j.bbcan.2022.188718
|
| 22 |
Saevar Ingthorsson, Eirikur Briem, Jon Thor Bergthorsson, Thorarinn Gudjonsson. Epithelial Plasticity During Human Breast Morphogenesis and Cancer Progression. Journal of Mammary Gland Biology and Neoplasia 2016; 21(3-4): 139 doi: 10.1007/s10911-016-9366-3
|
| 23 |
Rashi Arora, Apoorva Uboveja, Rama Kadamb. Cancer Epigenetics and Nanomedicine. 2024; : 93 doi: 10.1016/B978-0-443-13209-4.00018-0
|
| 24 |
Abhishek Mukherjee, Patrick Ha, Katherine C. Wai, Shorook Naara. The Role of ECM Remodeling, EMT, and Adhesion Molecules in Cancerous Neural Invasion: Changing Perspectives. Advanced Biology 2022; 6(9) doi: 10.1002/adbi.202200039
|
| 25 |
Minal Garg. Epithelial, mesenchymal and hybrid epithelial/mesenchymal phenotypes and their clinical relevance in cancer metastasis. Expert Reviews in Molecular Medicine 2017; 19 doi: 10.1017/erm.2017.6
|
| 26 |
Mazharul Haque, Ritis K. Shyanti, Manoj K. Mishra. Targeted therapy approaches for epithelial-mesenchymal transition in triple negative breast cancer. Frontiers in Oncology 2024; 14 doi: 10.3389/fonc.2024.1431418
|
| 27 |
Doaa Tawfik, Angela Zaccagnino, Alexander Bernt, Monika Szczepanowski, Wolfram Klapper, Albrecht Schwab, Holger Kalthoff, Anna Trauzold. The A818–6 system as an in-vitro model for studying the role of the transportome in pancreatic cancer. BMC Cancer 2020; 20(1) doi: 10.1186/s12885-020-06773-w
|
| 28 |
CUNEN WU, YUWEN ZHUANG, SHAN JIANG, SHENLIN LIU, JINYONG ZHOU, JIAN WU, YUHAO TENG, BAOMEI XIA, RUIPING WANG, XI ZOU. Interaction between Wnt/β-catenin pathway and microRNAs regulates epithelial-mesenchymal transition in gastric cancer (Review). International Journal of Oncology 2016; 48(6): 2236 doi: 10.3892/ijo.2016.3480
|
| 29 |
Z Zhang, M Zhang, Qinghan Chen, Q Zhang. Downregulation of microRNA-145 promotes epithelial–mesenchymal transition via regulating Snail in osteosarcoma. Cancer Gene Therapy 2017; 24(2): 83 doi: 10.1038/cgt.2017.1
|
| 30 |
Wilhem Leconet, Myriam Chentouf, Stanislas du Manoir, Clément Chevalier, Audrey Sirvent, Imade Aït-Arsa, Muriel Busson, Marta Jarlier, Nina Radosevic-Robin, Charles Theillet, Dany Chalbos, Jean-Max Pasquet, André Pèlegrin, Christel Larbouret, Bruno Robert. Therapeutic Activity of Anti-AXL Antibody against Triple-Negative Breast Cancer Patient-Derived Xenografts and Metastasis. Clinical Cancer Research 2017; 23(11): 2806 doi: 10.1158/1078-0432.CCR-16-1316
|
| 31 |
Kamoru A. Adedokun, Sikiru O. Imodoye, Ibrahim O. Bello, Abdul-Azeez Lanihun, Ibrahim O. Bello. Phytochemistry, Computational Tools and Databases in Drug Discovery. 2023; : 393 doi: 10.1016/B978-0-323-90593-0.00017-4
|
| 32 |
Hong-Liang Shen, Qing-Jun Liu, Pei-Qian Yang, Ye Tian. Protein interactions of cortactin in relation to invadopodia formation in metastatic renal clear cell carcinoma. Tumor Biology 2015; 36(5): 3417 doi: 10.1007/s13277-014-2976-8
|
| 33 |
Jie Li, Xia Gong, Rong Jiang, Dan Lin, Tao Zhou, Aijie Zhang, Hongzhong Li, Xiang Zhang, Jingyuan Wan, Ge Kuang, Hongyuan Li. Fisetin Inhibited Growth and Metastasis of Triple-Negative Breast Cancer by Reversing Epithelial-to-Mesenchymal Transition via PTEN/Akt/GSK3β Signal Pathway. Frontiers in Pharmacology 2018; 9 doi: 10.3389/fphar.2018.00772
|
| 34 |
Shilpa R. Raju, Sreenath Balakrishnan, Somanna Kollimada, K.N. Chandrashekara, Aruna Jampani. Anti-tumor effects of Artemisia nilagirica extract on MDA-MB-231 breast cancer cells: deciphering the biochemical and biomechanical properties via TGF-β upregulation. Heliyon 2020; 6(10): e05088 doi: 10.1016/j.heliyon.2020.e05088
|
| 35 |
ALAN P. LOMBARD, REBECCA M. LIM, RACHEL M. NAKAGAWA, KATHLEEN D. VIDALLO, STEPHEN J. LIBERTINI, ALEXANDER J. PLATERO, MARIA MUDRYJ. Dicer ablation promotes a mesenchymal and invasive phenotype in bladder cancer cells. Oncology Reports 2015; 34(3): 1526 doi: 10.3892/or.2015.4117
|
| 36 |
Javier Vaquero, Nathalie Guedj, Audrey Clapéron, Thanh Huong Nguyen Ho-Bouldoires, Valérie Paradis, Laura Fouassier. Epithelial-mesenchymal transition in cholangiocarcinoma: From clinical evidence to regulatory networks. Journal of Hepatology 2017; 66(2): 424 doi: 10.1016/j.jhep.2016.09.010
|
| 37 |
Neda Alidadiani, Shahrooz Ghaderi, Nafi Dilaver, Saina Bakhshamin, Mansour Bayat. Epithelial mesenchymal transition Transcription Factor (TF): The structure, function and microRNA feedback loop. Gene 2018; 674: 115 doi: 10.1016/j.gene.2018.06.049
|
| 38 |
Xianlu Zhuo, Huanli Luo, Aoshuang Chang, Dairong Li, Houyu Zhao, Qi Zhou. Is overexpression of TWIST, a transcriptional factor, a prognostic biomarker of head and neck carcinoma? Evidence from fifteen studies. Scientific Reports 2015; 5(1) doi: 10.1038/srep18073
|
| 39 |
Ivana Fridrichova, Iveta Zmetakova. MicroRNAs Contribute to Breast Cancer Invasiveness. Cells 2019; 8(11): 1361 doi: 10.3390/cells8111361
|
| 40 |
Shravanti Mukherjee, Shilpi Saha, Argha Manna, Minakshi Mazumdar, Samik Chakraborty, Shrutarshi Paul, Tanya Das. Targeting Cancer Stem Cells by Phytochemicals: a Multimodal Approach to Colorectal Cancer. Current Colorectal Cancer Reports 2014; 10(4): 431 doi: 10.1007/s11888-014-0251-4
|
| 41 |
Maxime Janin, Veronica Davalos, Manel Esteller. Cancer metastasis under the magnifying glass of epigenetics and epitranscriptomics. Cancer and Metastasis Reviews 2023; 42(4): 1071 doi: 10.1007/s10555-023-10120-3
|
| 42 |
Yuechao Zhao, Yiran Li, Jie Sheng, Fan Wu, Kai Li, Rong Huang, Xiaojuan Wang, Tao Jiao, Xin Guan, Yan Lu, Xiao Chen, Zhiwen Luo, Yanchi Zhou, Hanjie Hu, Wenjie Liu, Boyu Du, Shiying Miao, Jianqiang Cai, Linfang Wang, Hong Zhao, Jianming Ying, Xinyu Bi, Wei Song. P53-R273H mutation enhances colorectal cancer stemness through regulating specific lncRNAs. Journal of Experimental & Clinical Cancer Research 2019; 38(1) doi: 10.1186/s13046-019-1375-9
|
| 43 |
Xi Gu, Jin-Qi Xue, Si-Jia Han, Song-Ying Qian, Wen-Hai Zhang. Circulating microRNA-451 as a predictor of resistance to neoadjuvant chemotherapy in breast cancer. Cancer Biomarkers 2016; 16(3): 395 doi: 10.3233/CBM-160578
|
| 44 |
Zhe Zhang, Guojun Zhang, Chuize Kong, Jianbin Bi, Daxin Gong, Xiuyue Yu, Du Shi, Bo Zhan, Peng Ye. EIF2C, Dicer, and Drosha are up-regulated along tumor progression and associated with poor prognosis in bladder carcinoma. Tumor Biology 2015; 36(7): 5071 doi: 10.1007/s13277-015-3158-z
|
| 45 |
Sugandha Bhatia, James Monkman, Alan Kie Leong Toh, Shivashankar H. Nagaraj, Erik W. Thompson. Targeting epithelial–mesenchymal plasticity in cancer: clinical and preclinical advances in therapy and monitoring. Biochemical Journal 2017; 474(19): 3269 doi: 10.1042/BCJ20160782
|
| 46 |
Riccardo Di Fiore, Rosa Drago-Ferrante, Francesca Pentimalli, Domenico Di Marzo, Iris Maria Forte, Daniela Carlisi, Anna De Blasio, Giovanni Tesoriere, Antonio Giordano, Renza Vento. Let-7d miRNA Shows Both Antioncogenic and Oncogenic Functions in Osteosarcoma-Derived 3AB-OS Cancer Stem Cells. Journal of Cellular Physiology 2016; 231(8): 1832 doi: 10.1002/jcp.25291
|
| 47 |
Faezeh Karami, Narges Maleki, Arefeh Khazraei Monfared, Sayeh Jafari Marandi. Upregulation of miR-206 is a potential diagnostic biomarker in breast cancer. Bionatura 2021; 6(2): 1757 doi: 10.21931/RB/2021.06.02.15
|
| 48 |
Manish Ranjan, Oukseub Lee, Gannon Cottone, Elnaz Mirzaei Mehrabad, Benjamin T. Spike, Zexian Zeng, Shivangi Yadav, Robert Chatterton, J. Julie Kim, Susan E. Clare, Seema A. Khan. Progesterone receptor antagonists reverse stem cell expansion and the paracrine effectors of progesterone action in the mouse mammary gland. Breast Cancer Research 2021; 23(1) doi: 10.1186/s13058-021-01455-2
|
| 49 |
Soudeep Dey, Yirivinti Hayagreeva Dinakar, Soundarya R, Vikas Jain, Rupshee Jain. Navigating the therapeutic landscape for breast cancer: targeting breast cancer stem cells. Naunyn-Schmiedeberg's Archives of Pharmacology 2024; doi: 10.1007/s00210-024-03542-5
|